« Rep. Kennedy returning to work today in D.C. | Today | Providence restaurants to offer deals in July »

June 6, 2006

Amgen settles licensing dispute over Enbrel

Massachusetts General Hospital recently received $186 million from Amgen Inc. to settle a licensing dispute over the rheumatoid arthritis drug Enbrel.

Enbrel was created based on research developed by a scientist at Mass General, according to Boston Globe reports.

The drug was licensed to Immunex, which was purchased by Amgen. Amgen now manufactures the drug in West Greenwich and sells it in North America and internationally.

The settlement eliminates any additional royalty payments to Mass General on Enbrel sales in North America. Amgen sold $2.5 billion worth of Enbrel last year. Mass General will continue to earn royalties from the sale of the drug internationally.

-- Journal staff writer Andrea Stape

Posted by Jack Perry  at 12:21 PM | Permalink

Comments

Post a comment

Please be civil. Vicious comments, personal attacks and profanity won't be published. Name and email are required; email address will not publish.

Name:

Email Address:

URL:
Remember Me? YesNo

Comments: (you may use HTML tags for style)